SecBot SecBot
8-K ·Filed Oct 22, 2026

LNAI

Lunai Bioworks Inc.
BEARISH
Impact 9/10
Horizonimmediate Processed3d 22h ago SEC0001731122-26-001362
8-K context-dependent: Items 3.01, 5.02, 7.01, 8.01
Actionable Insight ▼ Bearish

LNAI common stock will be suspended from Nasdaq trading on October 30, 2026, with no OTC market expected. Existing shareholders face near-total illiquidity. The company is effectively going dark — filing a Form 15 to suspend SEC reporting. There is no path to regain listing or raise capital.

DirectionBearish
Confidencehigh
Horizonimmediate
Latest settled — T+1d
LNAI ▼ -6.65% at T+1d
SHORT call ✓ call won +6.65% · α vs SPY +7.36% · entry $0.2946 → $0.2750
Next anchor: T+5d in 2d
Entry = T+0 close
Oct 22, 2026
via day close
T+1d
-6.65%
call +6.65% · α +7.36%
$0.2750
settled 4d ago
T+5d
Pending
in 2d
T+20d
Pending
in 23d
T+60d
Pending
in 3mo

Price Chart

Loading chart...

Executive Summary

Lunai Bioworks received a Nasdaq delisting determination due to a stockholders' deficit of $(9,024,946), violating the $2.5M minimum equity rule. The company will not contest the delisting; instead, its board approved voluntary withdrawal from Nasdaq and intends to file a Form 25 on November 2, 2026, with delisting effective around November 12, 2026. Simultaneously, the CFO resigned, a board member resigned (breaking audit and compensation committee requirements), the ATM sales agreement was terminated, and all unsold securities under registration statements were deregistered — the company does not plan to arrange for OTC trading, effectively ending its public market life.

Key Facts

  • Nasdaq staff determined to delist LNAI due to stockholders' deficit of $(9,024,946) vs. $2,500,000 minimum equity requirement
  • Company will not request a hearing; board approved voluntary withdrawal from Nasdaq on October 22, 2026
  • Form 25 expected to be filed on or about November 2, 2026; delisting effective on or about November 12, 2026
  • Company intends to file Form 15 to suspend SEC reporting obligations; will not arrange for OTC quotation
  • CFO Nathen Fuentes resigned effective October 22, 2026; no successor or interim CFO named
  • Board member Douglas W. Calder resigned, breaking audit committee (needs 3 members) and compensation committee (needs 2 independent members) requirements
  • ATM Sales Agreement with Dawson James Securities terminated on October 16, 2026
  • Post-effective amendments filed to deregister all unsold securities under S-8 and S-3 registration statements
  • Market cap is $3M; trading suspension expected at open on October 30, 2026

Financial Impact

Stockholders' deficit of $(9,024,946); market cap of $3M; no trading market expected after delisting; all equity financing vehicles terminated

stockholdersEquitymarketCapliquidity

Risk Factors

  • Complete loss of liquidity — no OTC market expected after Nasdaq suspension
  • No CFO, broken board committees, and no plan to fill vacancies before delisting
  • Potential cessation of operations given inability to raise capital and termination of all equity financing facilities

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001731122-26-001362
Document: e8019_ex99-1.htm0001731122-26-001362
Document: 0001731122-26-001362-index-headers.html0001731122-26-001362
Document: 0001731122-26-001362-index.html0001731122-26-001362
Document: 0001731122-26-001362.txt0001731122-26-001362
10 reports for LNAI
Performance horizon
80% Hit rate @ T+1 4 of 5 directional calls Went positive at some point 4 of 5 best @ T+5▲ +56.62%Oct 15, 2026
Filters
Rows
Reports for LNAI — sortable, filterable
TypeNow
Oct 22, 2026
3d ago
8-K
BEARISH ★ 9/10
$0.2946 $0.2750▲ +6.65%▲ +7.36%$0.2950 (−0.14%)
Oct 15, 2026
10d ago
SC 13D/A
BEARISH ★ 6/10
$0.6800 $0.4720▲ +30.59%▲ +31.01%$0.2950 (+56.62%)
Oct 9, 2026
17d ago
8-K
BEARISH ★ 6/10
$1.23 $1.11▲ +9.76%▲ +9.70%$0.2950 (+76.02%)
Sep 29, 2026
27d ago
NT 10-K
BEARISH ★ 6/10
$1.47 $1.38▲ +6.12%▲ +6.30%$0.2950 (+79.93%)
Jun 17, 2026
18w ago
8-K
MIXED ★ 5/10
$3.78 $4.15▲ +9.79%▲ +10.10%$0.2950 (−92.20%)
Jun 16, 2026
18w ago
8-K
NEUTRAL ★ 4/10
$4.00 $3.78▼ −5.50%▼ −6.28%$0.2950 (−92.63%)
May 20, 2026
22w ago
8-K
BEARISH ★ 6/10
$1.80 $2.32▼ −28.89%▼ −28.69%$0.2950 (+83.61%)
May 1, 2026
25w ago
8-K
MIXED ★ 7/10
$2.60 $2.50▼ −3.88%▼ −4.68%$0.2950 (−88.64%)
Apr 28, 2026
25w ago
DEFA14A
NEUTRAL ★ 3/10
$2.66 $2.64▼ −0.90%▼ −1.92%$0.2950 (−88.93%)
Mar 5, 2026
33w ago
8-K
BEARISH ★ 8/10
$1.86 $1.76▲ +5.25%▲ +6.10%$0.2950 (+84.12%)
Showing 10 of 10

US Market Status

Market Closed — Opens Wed (13h 20m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 22, 2026